Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shanghai Pioneer HoldingHKSE:01345 +2.33%77 EV-to-FCF is 12.21 as of Aug. 18, 2026, which is 49% above its 10-year median of 8.21. GuruFocus rates HKSE:01345 with a GF Score™ of 77/100 and a GF Value™ of HK$1.79 (Modestly Overvalued). The stock has 8 warning signs investors should review. Among 409 Healthcare Providers & Services companies, Shanghai Pioneer Holding ranks better than 64.79% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Shanghai Pioneer Holding's Enterprise Value is HK$2,411 Mil.
Shanghai Pioneer Holding's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was HK$197 Mil. Therefore, Shanghai Pioneer Holding's EV-to-FCF for today is 12.21.
The historical rank and industry rank for Shanghai Pioneer Holding's EV-to-FCF or its related term are showing as below:
HKSE:01345'
s EV-to-FCF Range Over the Past 10 Years
Min: -244.64 Med: 8.21 Max: 137.05
Current: 12.51
During the past 13 years, the highest EV-to-FCF of Shanghai Pioneer Holding was 137.05. The lowest was -244.64. And the median was 8.21.
HKSE:01345's EV-to-FCF is ranked better than 64.79% of 409
companies
in the Healthcare Providers & Services industry
Industry Median: 18.66
vs HKSE:01345: 12.51
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Shanghai Pioneer Holding's PE Ratio (TTM) for today is calculated as:
Shanghai Pioneer Holding's share price for today is HK$2.20.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Shanghai Pioneer Holding's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$0.110.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Shanghai Pioneer Holding EV-to-FCF Related Terms
Shanghai Pioneer Holding EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Shanghai Pioneer Holding's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Pioneer Holding EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Shanghai Pioneer Holding's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Shanghai Pioneer Holding's EV-to-FCF falls into.
Shanghai Pioneer Holding's current Enterprise Value is HK$2,411 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Shanghai Pioneer Holding's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was HK$197 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Pioneer Holding (HKSE:01345) has a EV-to-FCF of 12.21 as of Aug. 18, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Shanghai Pioneer Holding and its competitors. This is 49% above median its historical median of 8.21. According to the industry distribution chart, Shanghai Pioneer Holding ranks #144 out of 409 companies in the Healthcare Providers & Services industry, placing it in the top 35.2%.
Is Shanghai Pioneer Holding's EV-to-FCF too high?
Shanghai Pioneer Holding's current EV-to-FCF of 12.21 is 49% above median its 10-year median of 8.21. The Healthcare Providers & Services industry median EV-to-FCF is 18.66. Shanghai Pioneer Holding's value of 12.21 is 34.6% below this industry median. Based on the distribution chart, Shanghai Pioneer Holding ranks #144 out of 409 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Shanghai Pioneer Holding has a GF Score™ of 77/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Pioneer Holding's EV-to-FCF compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Shanghai Pioneer Holding ranks #144 out of 409 companies for EV-to-FCF. This puts Shanghai Pioneer Holding in the upper half of its industry. The industry median EV-to-FCF is 18.66. Shanghai Pioneer Holding's value of 12.21 is 34.6% below this benchmark. While the company's 10-year median is 8.21 vs. the industry median of 18.66, Shanghai Pioneer Holding has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 18.66, based on 409 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Pioneer Holding's current EV-to-FCF of 12.21 is 34.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Shanghai Pioneer Holding and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 18.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Pioneer Holding's current EV-to-FCF is 12.21, which is 49% above median its own 10-year median of 8.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Pioneer Holding stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Pioneer Holding (HKSE:01345) is currently considered Modestly Overvalued. The stock's GF Value™ is HK$1.79, compared to a current price of HK$2.20 — trading 22.9% above its estimated fair value. The current EV-to-FCF is 12.21, which is 49% above median its 10-year median of 8.21 and 34.6% below the Healthcare Providers & Services industry median of 18.66. Shanghai Pioneer Holding's overall GF Score™ is 77/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Shanghai Pioneer Holding (HKSE:01345), the current EV-to-FCF is 12.21 as of Aug. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Pioneer Holding (HKSE:01345) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Pioneer Holding stock appears to be overvalued.
The current stock price of HK$2.20 is trading 22.9% above its estimated GF Value™ of HK$1.79.
GuruFocus considers Shanghai Pioneer Holding to be Modestly Overvalued.
Key valuation signals for HKSE:01345:
EV-to-FCF: 12.21 (49% above median its 10-year median of 8.21)
GF Value™: HK$1.79 vs. price of HK$2.20 (22.9% above fair value)
Industry Position: 34.6% below the Healthcare Providers & Services median (#144 of 409)
No single metric tells the full story. See the HKSE:01345 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Pioneer Holding Ltd is an investment holding company. Along with its subsidiaries, the company is engaged in the marketing, promotion, sales, and channel management service for imported pharmaceutical products and medical devices in China. The company has a portfolio of pharmaceutical products, covering ophthalmology, pain management, cardiovascular, gastroenterology, immunology, gynecology, and other therapeutic areas, and medical devices covering several medical specialties, including ophthalmology, odontology, cardiology and wound care products. The majority of its revenue derives from the Sales of medical equipment and supplies. The group operates mainly in the People's Republic of China.
77GF Score
Get the complete analysis for HKSE:01345
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01345 has been successfully added to your 
